🇺🇸 FDA
Patent

US 11230587

Ligands of B7H receptor in the treatment of osteopenia and osteoporosis

granted A61KA61K38/00A61P

Quick answer

US patent 11230587 (Ligands of B7H receptor in the treatment of osteopenia and osteoporosis) held by UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO” expires Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO”
Grant date
Tue Jan 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K38/00, A61P, A61P19/08, A61P19/10